ICAM1 and systemic sclerosis: The higher levels of ICAM-1 in SSc-ILD+ patients makes sense considering that it is essential for leukocyte diapedesis, being previously described as a contributor to the development of inflammation and fibrosis in SSc via induction of the infiltration and activation of leukocytes [35].